Sexual Dysfunction: Selective Serotonin Reuptake Inhibitors
Commons · Question 9558 · Tabled 16 Oct 2024 · Department of Health and Social Care · Official record
Answered 22 Oct 2024
Question
Asked by Darren Paffey
To ask the Secretary of State for Health and Social Care, what progress the Commission for Human Medicines has made on its review of how the risk of sexual dysfunction is communicated to patients; and whether that review includes the potential effects of
Answer
Answered by Karin Smyth, 22 Oct 2024
The first meeting of the Expert Working Group (EWG) on antidepressant risk minimisation convened by the Medicine and Healthcare products Regulatory Agency, on the advice of the Commission on Human Medicines, was held on 4 July 2024.At the initial meeting ...